Urgent.News

What's breaking now, across thousands of outlets.

Science

Age-dependent phosphorylation of estrogen receptor beta (ERβ) regulates homodimer formation and impairs the repression of amyloid precursor protein (APP) promoter.

Estrogen receptor beta (ER{beta}) is a ligand-activated nuclear steroid receptor that promotes neuroprotection through its transcriptional coordination of healthy cell gene programs. However, circulating estrogens are dramatically reduced post-menopause and the administration of hormone replacement therapy is only beneficial within a narrowly restricted timeframe after the menopause transition.…

Estrogen receptor beta (ERβ) is a protein that benefits the brain by coordinating healthy gene activity. However, after menopause, estrogen levels drop and hormone replacement therapy only helps for a short period after the menopause transition. The reason ERβ struggles to offer protection in older age remains unclear. It appears that changes in protein interactions due to aging might hinder ERβ's transcriptional function.

Protein interactions can be altered by phosphorylation, a chemical modification of specific amino acids. Previous research revealed that ERβ phosphorylation varies with age, prompting the idea that ERβ phosphorylation is necessary for ERβ interactions, especially ERβ dimer formation. To test this hypothesis, the study employed fluorescence lifetime measurements to quantify Förster resonance energy transfer (FRET) of ERβ phosphomutant protein interactions.

The findings indicate that phosphorylation of ERβ-S176, S200, and Y488 reduces ERβ homodimer formation, implying an age-related molecular mechanism that influences ERβ's genomic signaling. Furthermore, phosphorylation at S200 and Y488 results in a loss of ERβ's ability to repress the amyloid precursor protein (APP) promoter, indicating that these age-dependent PTMs directly affect ERβ's role as a transcription factor.

Overall, these results suggest that age-related changes in ERβ phosphorylation lead to diminished ERβ genomic signaling, potentially diminishing the neuroprotective effects of estrogens post-menopause.

Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at biorxiv.org →

More in Science

More from Tuesday 17 November →